Skip to main content

Table 2 Clinical Characteristics of patients with Rheumatic Mitral Stenosis

From: Proteomic analysis of human plasma in chronic rheumatic mitral stenosis reveals proteins involved in the complement and coagulation cascade

Patient

Age

Sex

h/o RF

NYHA

Pulse

AF

SBP

DBP

Type of MS

P1

41

M

Y

I

80

N

120

70

Severe MS + Moderate AR

P2

42

F

N

II

88

Y

110

80

severe MS + Moderate MR + mild AR

P3

45

M

Y

I

72

N

130

90

Severe MS + Moderate MR + Mild AS + Moderate TR

P4

35

M

Y

I

60

N

110

60

Severe MS + Moderate AR + Moderate TR + Mild MR

P5

24

M

N

I

78

Y

110

66

Severe MS + Moderate MR

P6

26

M

N

I

78

N

120

90

Moderate MS + Mild AR

P7

33

F

Y

I

78

N

130

90

Severe MS + Mild AR

P8

35

M

Y

I

60

Y

120

90

Severe MS + Moderate TR + Mild MR

P9

45

F

Y

III

77

N

100

70

Severe MS

P10

35

M

N

III

80

N

100

60

Moderate MS

P11

33

M

N

I

66

N

100

80

Severe MS + Mild MR + Mild TR + Mild AS

P12

36

F

Y

IV

84

N

110

60

Severe MS + Severe TR

P13

48

M

Y

I

84

N

120

80

Severe MS

P14

25

F

Y

I

70

Y

100

60

Severe MS

P15

35

F

N

I

96

N

100

70

Severe MS + Mild TR

P16

32

F

N

I

58

Y

80

50

Severe MS

P17

55

M

N

II

60

Y

140

80

Severe MS

P18

33

F

Y

I

76

N

100

70

Severe MS + Mild MR

P19

40

F

N

I

108

N

110

80

Severe MS

P20

19

M

N

I

70

N

100

70

Severe MS

P21

38

F

Y

I

64

Y

80

50

Severe MS + Mild MR + Moderate AR

P22

42

M

Y

III

64

N

140

100

Severe MS + Moderate AS + Moderate AR

P23

24

F

Y

III

120

N

110

80

Severe MS + Moderate AS

P24

27

M

Y

II

62

Y

130

100

Severe MS + Mild MR

P25

48

M

Y

II

100

N

140

100

Severe MS + Moderate TR

P26

40

F

Y

III

80

N

110

70

Severe MS + Mild MR

P27

28

M

Y

II

70

N

110

70

Severe MS + Moderate MR

P28

35

F

Y

II

80

Y

120

80

Severe MS + Moderate TR + Mild MR

P29

43

F

Y

II

100

Y

120

80

Severe MS + Severe TR + Moderate AR

P30

35

M

Y

II

100

Y

120

70

Severe MS + Moderate AR

P31

50

M

Y

II

80

N

130

70

Severe MS + Moderate AS + Moderate AR

P32

47

F

Y

II

110

N

130

80

Severe MS + Moderate MR + Moderate TR + Moderate AR

P33

46

M

Y

IV

50

Y

140

80

Severe MS + Mild MR + Severe TR

P34

30

M

N

III

60

N

120

80

Moderate MS + Mild AR

P35

36

M

N

II

80

N

110

70

Severe MS + Mild AR + Severe TR

  1. AF atrial fibrillation, AR aortic regurgitation, AS aortic stenosis, bpm beats per minute, DBP diastolic blood pressure, F female, h/o RF history of Rheumatic Fever, M male, MR mitral regurgitation, MS mitral stenosis, N no, NYHA new york heart association, P patient, SBP systolic blood pressure, TR tricuspid regurgitation.
Back to article page

Clinical Proteomics

ISSN: 1559-0275